Microbial Degradation of Lignocellulosic Waste and Its Metabolic Products

2016 ◽  
pp. 263-312 ◽  
2020 ◽  
Vol 27 ◽  
Author(s):  
Antonis D. Tsiailanis ◽  
Andreas G. Tzakos ◽  
Thomas Mavromoustakos

: Drugs have to overcome numerous barriers to reach their desired therapeutic targets. In several cases drugs, especially the highly lipophilic molecules, suffer from low solubility and bioavailability and therefore their desired targeting is hampered. In addition, undesired metabolic products might be produced or off-targets could be recognized. Along these lines, nanopharmacology has provided new technological platforms, to overcome these boundaries. Specifically, numerous vehicle platforms such as cyclodextrins and calixarenes have been widely utilized to host lipophilic drugs such as antagonists of the angiotensin II AT1 receptor (AT1R), as well as quercetin and silibinin. The encapsulation of these drugs in supramolecules or other systems refines their solubility and metabolic stability, increases their selectivity and therefore decreases their effective dose and improves the therapeutic index. In this minireview we report on the formulations of Silibinin and AT1R antagonist candesartan in a 2-HP-β-cyclodextrin host molecule, which displayed enhanced cytotoxicity and increased silibinin’s and candesartan’s stability, respectively. Moreover we describe the encapsulation of quercetin in gold nanoparticles bearing a calixarene supramolecular host. Also the encapsulation of temozolomide in a calixarene nanocapsule has been described. Finally, we report on the activity enhancement that has been achieved upon using these formulations as well as the analytical and computational methods we used to characterize these formulations and explore the molecular interactions between the host and quest molecules.


Geology ◽  
2020 ◽  
Author(s):  
C.R. Woltz ◽  
S.M. Porter ◽  
H. Agić ◽  
C.M. Dehler ◽  
C.K. Junium ◽  
...  

Much of our understanding of early eukaryote diversity and paleoecology comes from the record of organic-walled microfossils in shale, yet the conditions controlling their preservation are not well understood. It has been suggested that high concentrations of total organic carbon (TOC) inhibit the preservation of organic fossils in shale, and although this idea is supported anecdotally, it has never been tested. Here we compared the presence, preservational quality, and assemblage diversity of organic-walled microfossils to TOC concentrations of 346 shale samples that span the late Paleoproterozoic to middle Neoproterozoic in age. We found that fossil-bearing samples have significantly lower median TOC values (0.32 wt%, n = 189) than those containing no fossils (0.72 wt%, n = 157). Preservational quality, measured by the loss of surface pattern, density of pitting, and deterioration of wall margin, decreases as TOC increases. Species richness negatively correlates with TOC within the ca. 750 Ma Chuar Group (Arizona, USA), but no relationship is observed in other units. These results support the hypothesis that high TOC content either decreases the preservational quality or inhibits the preservation of organic-walled microfossils altogether. However, it is also possible that other causal factors, including sedimentation rate and microbial degradation, account for the correlation between fossil preservation and TOC. We expect that as TOC varies in space and time, so too does the probability of finding well-preserved fossils. A compilation of 13,940 TOC values spanning Earth history suggests significantly higher median TOC levels in Mesoproterozoic versus Neoproterozoic shale, potentially biasing the interpreted pattern of increased eukaryotic diversity in the Tonian.


2021 ◽  
pp. 128437
Author(s):  
Chaoyang Lu ◽  
Wenzhe Li ◽  
Quanguo Zhang ◽  
Linghui Liu ◽  
Ningyuan Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document